Indiana Board of Pharmacy

Temporary Waiver from E-Prescribing Requirement: If a practitioner believes they may be eligible for a waiver from the e-prescribing requirements effective Jan. 1, 2021; they may visit the State Board of Pharmacy’s website to apply for a waiver. More information, including the reasons for which a waiver may be approved can be found HERE.

Changes to Pharmacy Technician Oversight-  25-26-13-18.5 & IC 25-26-19-2: Pursuant to Executive Order 20-12, each pharmacist may now supervise 8 pharmacy technicians instead of 6. Additionally, pharmacy technicians may work remotely for non-dispensing job functions such as data entry, insurance processing or other roles that do not require the physical presence. 

Non-Controlled Substance Prescription Extensions- IC 25-26-13-25(d)(8): Pursuant to Executive Order 20-12, a pharmacist may give a one-time, 90-day emergency refill for a prescription of a non-controlled substance prescribed as a maintenance medication. 

Controlled Substance Prescribing via Telemedicine- IC 25-1-9.5-8: Pursuant to Executive Orders 20-13, a prescriber may prescribe a Schedule II-V controlled substance via telemedicine as long as the following conditions are met:
1. The prescription is issued for a legitimate medical purpose by a prescriber acting in their usual professional practice; 
2. The initial telecommunication is conducted using an audio-visual, real-time, two-way interactive communication system; and
3. All other applicable state and federal laws are followed.

Once a prescriber has conducted an in-person medical evaluation or has conducted an evaluation using an audio-visual, real-time, two-way interactive communication system for the initial prescription; further health consultation may be done via audio-only or audio-visual telecommunication, as long as all other applicable state and federal laws are followed.

Guidance for Prescribing and Dispensing of COVID-19 Related Drugs: The Indiana Board of Pharmacy and Medical Licensing Board have issued a joint statement providing guidance to healthcare professionals relating to prescribing and dispensing of hydroxychloroquine, chloroquine, and azithromycin. The guidance discourages these drugs from being prescribed for prophylactic use for COVID-19 and encourages professional caution in fulfilling any prescription of these drugs. Additionally, the boards are suggesting that any prescription for these drugs be limited to a 14-day supply wherever medically appropriately. A copy of the guidance may be found HERE. 

Critical Fingerprinting: The following license types have been deemed critical by the Indiana Department of Administration and will be given priority for the purposes of getting fingerprinting completed. 
License Types: Pharmacists, Pharmacy Technicians and Training

PLA Remote Work: In response to COVID-19 and the impact it is having on the State of Indiana, the Professional Licensing Agency will have the majority of our staff working remotely in the coming weeks. While routine operations of the agency will continue, please note that there may be disruptions or delays in the processing of your requests. Please prioritize the usage of email to communicate with our staff whenever possible and scan any documents (except applications) that need to be processed. We appreciate your patience and flexibility as we work best to protect our staff and serve Hoosiers in these ever-changing times.

Notice of Emergency Rulemaking: The Indiana Board of Pharmacy has promulgated emergency rules which add two additional substances to Indiana's Controlled Substance list. These substances were added in order to comply with changes made by the DEA. A copy of the emergency rule may be found HERE.

Statewide standing order for tobacco cessation products

Tobacco cessation protocol 8.1.2019

Licensing Information

Effective immediately: Due to statutory requirements regarding processing times for application fees, the Indiana Professional Licensing Agency will no longer accept more than ten (10) fees per individual check for the application or renewal of a license issued by the Indiana Board of Pharmacy.

If a check is received with more than ten (10) fees per check, it may result in the return of your check along with the applications or renewals to your program for correction.  Further delays in processing time, as a result of more than ten (10) fees per check, may also lead to potential late fees. We apologize for any inconvenience this may cause and appreciate your partnership as we continue to work together to issue licenses as quickly and efficiently as possible. 

If you have any questions regarding this matter, please email pla4@pla.in.gov.

Resources

Controlled Substance Prescriptions
E-Prescribing Waivers
Criminal Background Check Information
Renewal Forms 
Fee Schedule
Pharmacy Laws & Regulations
Internet Drug Outlet Identification Program
INSPECT query waiver procedure
Announcements
E-Prescribing and Electronic Data Intermediaries
Frequently Asked Questions

Board of Pharmacy Information

Board of Pharmacy Members
Meeting Dates
Minutes & Agendas
Controlled Substances Advisory Committee
Electronic Meeting Policy